Ceftolozane-tazobactam
| Effect of ECMO | CS data conflicting; minimal effect on PK parameters |
|---|---|
| Dose recommendation | ECMO-specific dose adjustment not required |
| Comments, reference | Data from ex vivo, in vivo studies and case reports (Crit Care 2024;28:326). |